Stock listing
Amcad Biomed Corporation
Selected listing: 4188 · TPEX · TWD · TW
Amcad Biomed Corporation (TPEx:4188), Technology Services. Latest release Aug 9, 2022: AmCad BioMed : BOD approve the 2022 second quarter consolidated…
- Ticker
- TPEx:4188
- Asset type
- Stock
- Sector
- Technology Services
- Industry
- Packaged Software
- Exchange
- TPEx
- Currency
- TWD
About Amcad Biomed Corporation
Amcad Biomed Corporation, trading under the ticker 4188, is a public company listed on the Taiwan market. Amcad Biomed focuses on innovative biomedicine solutions and aims to advance healthcare through its research and development efforts.
Latest news from Amcad Biomed Corporation
AmCad BioMed : BOD approve the 2022 second quarter consolidated financial statements
August 9, 2022
AmCad BioMed : On behalf of our subsidiary Broadsound Co., we announce the major resolutions of 2022 Annual General Shareholders' Meeting.
June 9, 2022
AmCad BioMed : The major resolutions of 2022 Annual General Shareholders' Meeting.
May 20, 2022
AmCad BioMed : Announcing termination of private equity offering which was approved by 2021 Annual Shareholders' Meeting.
February 18, 2022
AmCad BioMed : Change to the spokesperson, financial and accounting officer
February 18, 2022
Research Amcad Biomed Corporation
Amcad Biomed Corporation company profile
View the public company page for Amcad Biomed Corporation on 6ix.
Amcad Biomed Corporation news
Read company news and market updates connected to Amcad Biomed Corporation.
Amcad Biomed Corporation investor events
Find investor webinars, events, and replay context for Amcad Biomed Corporation.